9 research outputs found
Madge - Microplate Array Diagonal Gel Electrophoresis
Microplate array diagonal gel electrophoresis (MADGE) was invented for molecular genetic epidemiological studies. MADGE is a highly flexible, cost effective, microplate compatible solution to high throughput electrophoresis needs. It enables several thousands to million gel lines per day for direct assay of single-base variation in different capacity laboratories. Variants of the standard 96-well MADGE include: 96-well stretch-MADGE, 192-well MADGE, 384-well MADGE, and 768-well MADGE. Melt-MADGE combines the temporal thermal ramp apparatus to achieve similar throughput for de novo mutation scanning. Basic MADGE principles and procedures, preparation of MADGE gels, electrophoresis, visualization and analysis of these gels, as well as modifications of the basic 96-well MADGE will be discussed in detail. For the first time in our country, this revolutionary polyacrylamid electrophoresis was done in 1998. We shortly review our studies which used MADGE for high throughput genotyping of the apolipoprotein E. MADGE and melt-MADGE will have an important role in the future genetic research of complex diseases and especially in pharmacogenomics.5th EFCC Symposium on Proteins - From Electrophoresis to Proteomics, 2009, Belgrade, Serbi
The role of CRP and inflammation in the pathogenesis of age-related macular degeneration
Age-related macular degeneration (AMD) is a complex, degenerative and progressive disease invol-ving the multiple genetic and environmental factors that can result in severe visual loss. The etiology of AMD is not well understood. Many theories exist and feature mechanisms of oxidative stress, athe-rosclerotic-like changes, genetic predisposition and inflammation. The most recent clinical studies appointed to a great role of inflammation and C-reactive protein (CRP) in the pathogenesis of AMD. There is a large body of evidence indicating the association of CRP with endothelial dysfunction, oxidative stress and production of reactive oxygen species (ROS), as well as with lipid status disorder in AMD patients. According to recent studies, CRP is definitely not only the inflammatory marker but also a mediator of development of the vascular disorders in the retinal circulation. The results obtai-ned from the present studies may help our understanding the pathogenesis of the retinal vascular disease associated with high levels of CRP
Is an integrative laboratory algorithm more effective in detecting alpha-1-antitrypsin deficiency in patients with premature chronic obstructive pulmonary disease than AAT concentration based screening approach?
Introduction: Alpha-1-antitrypsin deficiency (AATD), genetic risk factor for premature chronic obstructive pulmonary disease (COPD), often remains undetected. The aim of our study was to analyse the effectiveness of an integrative laboratory algorithm for AATD detection in patients diagnosed with COPD by the age of 45 years, in comparison with the screening approach based on AAT concentration measurement alone. Subjects and methods: 50 unrelated patients (28 males / 22 females, age 52 (24-75 years) diagnosed with COPD before the age of 45 years were enrolled. Immunonephelometric assay for alpha-1-antitrypsin (AAT) and PCR-reverse hybridization for Z and S allele were first-line, and isoelectric focusing and DNA sequencing (ABI Prism BigDye) were reflex tests. Results: AATD associated genotypes were detected in 7 patients (5 ZZ, 1 ZM(malton), 1 ZQ0(amersfoort)), 10 were heterozygous carriers (8 MZ and 2 MS genotypes) and 33 were without AATD (MM genotype). Carriers and patients without AATD had comparable AAT concentrations (P = 0.125). In majority of participants (48) first line tests were sufficient to analyze AATD presence. In two remaining cases reflex tests identified rare alleles, M-malton and Q0(amersfoort), the later one being reported for the first time in Serbian population. Detection rate did not differ between algorithm and screening both for AATD (P = 0.500) and carriers (P = 0.063). Conclusion: There is a high prevalence of AATD affected subjects and carriers in a group of patients with premature COPD. The use of integrative laboratory algorithm does not improve the effectiveness of AATD detection in comparison with the screening based on AAT concentration alone
The EC4 European syllabus for post-graduate training in clinical chemistry and laboratory medicine : Version 4-2012
Laboratory medicine’s practitioners across the European
community include medical, scientific and pharmacy trained
specialists whose contributions to health and healthcare is
in the application of diagnostic tests for screening and early
detection of disease, differential diagnosis, monitoring,
management and treatment of patients, and their prognostic
assessment. In submitting a revised common syllabus for
post-graduate education and training across the 27 member
states an expectation is set for harmonised, high quality,
safe practice. In this regard an extended ‘Core knowledge,
skills and competencies’ division embracing all laboratory
medicine disciplines is described. For the first time the syllabus
identifies the competencies required to meet clinical
leadership demands for defining, directing and assuring
the efficiency and effectiveness of laboratory services as
well as expectations in translating knowledge and skills
into ability to practice. In a ‘Specialist knowledge’ division,
the expectations from the individual disciplines of Clinical
Chemistry/Immunology, Haematology/Blood Transfusion,
Microbiology/ Virology, Genetics and In Vitro Fertilisation
are described. Beyond providing a common platform of
knowledge, skills and competency, the syllabus supports the
aims of the European Commission in providing safeguards
to increasing professional mobility across European borders
at a time when demand for highly qualified professionals is
increasing and the labour force is declining. It continues to
act as a guide for the formulation of national programmes
supplemented by the needs of individual country priorities.peer-reviewe